Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;87(6):931-41.
doi: 10.1007/s11524-010-9495-8.

Overdose prevention and naloxone prescription for opioid users in San Francisco

Affiliations

Overdose prevention and naloxone prescription for opioid users in San Francisco

Lauren Enteen et al. J Urban Health. 2010 Dec.

Abstract

Opiate overdose is a significant cause of mortality among injection drug users (IDUs) in the United States (US). Opiate overdose can be reversed by administering naloxone, an opiate antagonist. Among IDUs, prevalence of witnessing overdose events is high, and the provision of take-home naloxone to IDUs can be an important intervention to reduce the number of overdose fatalities. The Drug Overdose Prevention and Education (DOPE) Project was the first naloxone prescription program (NPP) established in partnership with a county health department (San Francisco Department of Public Health), and is one of the longest running NPPs in the USA. From September 2003 to December 2009, 1,942 individuals were trained and prescribed naloxone through the DOPE Project, of whom 24% returned to receive a naloxone refill, and 11% reported using naloxone during an overdose event. Of 399 overdose events where naloxone was used, participants reported that 89% were reversed. In addition, 83% of participants who reported overdose reversal attributed the reversal to their administration of naloxone, and fewer than 1% reported serious adverse effects. Findings from the DOPE Project add to a growing body of research that suggests that IDUs at high risk of witnessing overdose events are willing to be trained on overdose response strategies and use take-home naloxone during overdose events to prevent deaths.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Components of 10−30-min trainings conducted by DOPE Project staff for all participants receiving take-home naloxone.
FIGURE 2
FIGURE 2
Cumulative number of opioid overdose responses with naloxone reported by DOPE Project participants receiving refills, by year, 2003−2009.

Similar articles

Cited by

References

    1. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS data brief, no 22. Hyattsville, MD: National Center for Health Statistics; 2009. - PubMed
    1. Substance Abuse and Mental Health Services Administration OAS . Drug Abuse Warning Network, 2003: Area Profiles of Drug-Related Mortality. Rockville, MD: U.S. Department of Health and Human Services; 2005.
    1. Latkin CA, Hua W, Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend. 2004;73(1):61–67. doi: 10.1016/j.drugalcdep.2003.09.005. - DOI - PubMed
    1. Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug Alcohol Depend. 2007;88(2-3):182–187. doi: 10.1016/j.drugalcdep.2006.10.006. - DOI - PMC - PubMed
    1. Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130(7):584–590. - PubMed